EP
ABBV icon

EPIQ Partners’s AbbVie ABBV Stock Holding History

EPIQ Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751K Sell
2,985
-700
-19% -$151K 0.32% 50
2026
Q1 		$801K Hold
3,685
– – 0.37% 48
2025
Q4 		$842K Hold
3,685
– – 0.39% 46
2025
Q3 		$853K Hold
3,685
– – 0.4% 46
2025
Q2 		$684K Hold
3,685
– – 0.35% 47
2025
Q1 		$772K Hold
3,685
– – 0.41% 47
2024
Q4 		$655K Hold
3,685
– – 0.35% 48
2024
Q3 		$728K Hold
3,685
– – 0.4% 47
2024
Q2 		$632K Sell
3,685
-68
-2% -$11.3K 0.43% 43
2024
Q1 		$683K Sell
3,753
-13,827
-79% -$2.38M 0.45% 44
2023
Q4 		$2.72M Sell
17,580
-740
-4% -$108K 1.95% 22
2023
Q3 		$2.73M Sell
18,320
-885
-5% -$130K 2.06% 19
2023
Q2 		$2.59M Sell
19,205
-60
-0.3% -$8.8K 1.76% 22
2023
Q1 		$3.07M Buy
19,265
+40
+0.2% +$6.12K 2.12% 18
2022
Q4 		$3.11M Sell
19,225
-1,800
-9% -$276K 2.07% 19
2022
Q3 		$2.82M Buy
21,025
+975
+5% +$140K 1.75% 22
2022
Q2 		$3.07M Buy
20,050
+320
+2% +$48.9K 1.88% 21
2022
Q1 		$3.2M Buy
19,730
+1,800
+10% +$261K 1.72% 21
2021
Q4 		$2.43M Sell
17,930
-4,386
-20% -$518K 1.29% 31
2021
Q3 		$2.41M Buy
22,316
+3,850
+21% +$440K 1.11% 35
2021
Q2 		$2.08M Buy
18,466
+696
+4% +$78.4K 1.04% 35
2021
Q1 		$1.92M Buy
17,770
+1,375
+8% +$147K 1.1% 34
2020
Q4 		$1.76M Buy
16,395
+3,335
+26% +$320K 1.22% 33
2020
Q3 		$1.08M Sell
13,060
-700
-5% -$65.9K 0.82% 42
2020
Q2 		$1.35M Sell
13,760
-200
-1% -$17.6K 1.23% 32
2020
Q1 		$1.06M Buy
13,960
+475
+4% +$40.5K 1.18% 37
2019
Q4 		$1.19M Buy
+13,485
New +$1.12M 1.21% 36

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

EPIQ Partners's ABBV Position: Q2 2026 in Review

EPIQ Partners reduced its AbbVie (ABBV) stake by 19% in Q2 2026, selling an estimated $151K and leaving 2,985 shares worth $751K. The position accounts for 0.32% of the portfolio, ranked #50.

EPIQ Partners first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.2M in Q1 2022. 941 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • EPIQ Partners held 2,985 shares of AbbVie worth $751K as of Q2 2026.
  • EPIQ Partners sold 700 AbbVie shares in Q2 2026, an estimated $151K.
  • AbbVie made up 0.32% of EPIQ Partners's portfolio in Q2 2026, its #50 holding.
  • EPIQ Partners first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • EPIQ Partners's AbbVie position peaked at $3.2M in Q1 2022.
  • 941 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EPIQ Partners's 13F filing for Q2 2026, filed 7 Jul 2026.